FDA panel endorses GRAIL’s multi-cancer early detection test
The panel voted 7-2 vote in favour of GRAIL’S Galleri multi-cancer early detection (MCED) test’s benefits outweighing its risks.
The panel voted 7-2 vote in favour of GRAIL’S Galleri multi-cancer early detection (MCED) test’s benefits outweighing its risks.
Amid this probe, experts point to the importance of airtight AI governance when implementing the technology in high-risk contexts.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme
Intuitive Surgical expands platforms despite market headwind
The increased importance of safety for wearable devices